The blood-brain barrier limits the therapeutic efficacy of antibody drug conjugates in glioblastoma. Abounader R, Schiff D. Neuro Oncol 2021 Sep 13. pii: 6369406. doi: 10.1093.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Abounader R, Schiff D. The blood-brain barrier limits the therapeutic efficacy of antibody drug conjugates in glioblastoma. Neuro Oncol 2021 Sep 13. pii: 6369406. doi: 10.1093.
PMID: 34515791